Quetiapine Fumarate Market

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Quetiapine Fumarate Market contains market size and forecasts of Quetiapine Fumarate in global, including the following market information:
Global Quetiapine Fumarate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Quetiapine Fumarate Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Quetiapine Fumarate companies in 2021 (%)
The global Quetiapine Fumarate market was valued at 164.3 million in 2021 and is projected to reach US$ 141.6 million by 2028, at a CAGR of -2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immediate Release Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Quetiapine Fumarate include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical and Hunan Dongting Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Quetiapine Fumarate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Quetiapine Fumarate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Quetiapine Fumarate Market Segment Percentages, by Type, 2021 (%)
Immediate Release Tablets
Extended Release Tablets
Global Quetiapine Fumarate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Quetiapine Fumarate Market Segment Percentages, by Application, 2021 (%)
Adult
Others
Global Quetiapine Fumarate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Quetiapine Fumarate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Quetiapine Fumarate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Quetiapine Fumarate revenues share in global market, 2021 (%)
Key companies Quetiapine Fumarate sales in global market, 2017-2022 (Estimated), (MT)
Key companies Quetiapine Fumarate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical